These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3127096)

  • 1. Defective in vitro gamma interferon production and elevated serum immunoreactive thymosin beta 4 levels in patients with inflammatory bowel disease.
    Mutchnick MG; Lee HH; Hollander DI; Haynes GD; Chua DC
    Clin Immunol Immunopathol; 1988 Apr; 47(1):84-92. PubMed ID: 3127096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine production in patients with inflammatory bowel disease.
    Nakamura M; Saito H; Kasanuki J; Tamura Y; Yoshida S
    Gut; 1992 Jul; 33(7):933-7. PubMed ID: 1644332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymosin-dependent T-lymphocyte response in inflammatory bowel disease.
    Dopp AC; Mutchnick MG; Goldstein AL
    Gastroenterology; 1980 Aug; 79(2):276-82. PubMed ID: 6967439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of interferon-γ in bowel disease pathogenesis by nitric oxide pathway: a study in Algerian patients.
    Rafa H; Amri M; Saoula H; Belkhelfa M; Medjeber O; Boutaleb A; Aftis S; Nakmouche M; Touil-Boukoffa C
    J Interferon Cytokine Res; 2010 Sep; 30(9):691-7. PubMed ID: 20626296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.
    Mueller C; Knoflach P; Zielinski CC
    Gastroenterology; 1990 Mar; 98(3):639-46. PubMed ID: 2298368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum interferon activity in inflammatory bowel disease. Arachidonic acid release and lipoxygenation activated by alpha-class interferon in human neutrophils.
    Nielsen OH; Elmgreen J; Ahnfelt-Rønne I
    Inflammation; 1988 Apr; 12(2):169-79. PubMed ID: 2839422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune system alterations in patients with inflammatory bowel disease during remission.
    Sventoraityte J; Zvirbliene A; Kiudelis G; Zalinkevicius R; Zvirbliene A; Praskevicius A; Kupcinskas L; Tamosiūnas V
    Medicina (Kaunas); 2008; 44(1):27-33. PubMed ID: 18277086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of interferon gamma in the pathogenesis of Crohn's disease.
    Sasaki T; Hiwatashi N; Yamazaki H; Noguchi M; Toyota T
    Gastroenterol Jpn; 1992 Feb; 27(1):29-36. PubMed ID: 1555746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactive thymosin alpha 1 is associated with murine T-cell lymphomas.
    Zatz MM; McClure JE; Goldstein AL
    Leuk Res; 1984; 8(6):1003-10. PubMed ID: 6096635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse correlation between age related abnormalities of T-cell immunity and circulating thymosin alpha 1 levels in haemophilia A.
    Kessler CM; Schulof RS; Alabaster O; Goldstein AL; Naylor PH; Phillips TM; Luban NL; Kelleher JF; Reaman GH
    Br J Haematol; 1984 Oct; 58(2):325-36. PubMed ID: 6236839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine production in whole blood cell cultures of patients with Crohn's disease and ulcerative colitis.
    Elsässer-Beile U; von Kleist S; Gerlach S; Gallati H; Mönting JS
    J Clin Lab Anal; 1994; 8(6):447-51. PubMed ID: 7869186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.
    Aparició-Pagés MN; Verspaget HW; Peña AS; Weterman IT; de Bruin PA; Mieremet-Ooms MA; van der Zon JM; van Tol EA; Lamers CB
    J Clin Lab Immunol; 1989 Jul; 29(3):119-24. PubMed ID: 2517428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis.
    Meyers S; Sacher DB; Taub RN; Janowitz HD
    Gut; 1976 Nov; 17(11):911-5. PubMed ID: 1087263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease.
    Colpaert S; Vastraelen K; Liu Z; Maerten P; Shen C; Penninckx F; Geboes K; Rutgeerts P; Ceuppens JL
    Eur Cytokine Netw; 2002; 13(4):431-7. PubMed ID: 12517728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.
    Husain N; Tokoro K; Popov JM; Naides SJ; Kwasny MJ; Buchman AL
    J Clin Gastroenterol; 2013 Mar; 47(3):246-51. PubMed ID: 23269308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T lymphocyte subsets in inflammatory bowel disease: peripheral blood.
    Selby WS; Jewell DP
    Gut; 1983 Feb; 24(2):99-105. PubMed ID: 6221976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating thymulin and thymosin-alpha 1 activity in pediatric acquired immune deficiency syndrome: in vivo and in vitro studies.
    Rubinstein A; Novick BE; Sicklick MJ; Bernstein LJ; Incefy GS; Naylor PH; Goldstein AL
    J Pediatr; 1986 Sep; 109(3):422-7. PubMed ID: 3018210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.